A proposed restructuring exercise would give water treatment firm Hyflux a reboot that could gain it up to $258 million in working capital.
But its fate lies in the hands of investors and if they will vote in favour of the proposed deal, which will see the bulk of Hyflux's share capital, 60 per cent, going to SM Investments (SMI), a consortium of Indonesia's Salim Group and energy giant Medco Group.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
